5‐Fluorouracil and its active metabolite FdUMP cause DNA damage in human SW620 colon adenocarcinoma cell line
- 29 December 2008
- journal article
- research article
- Published by Wiley in Journal of Applied Toxicology
- Vol. 29 (4) , 308-316
Abstract
5‐Fluorouracil (5‐FU) is an antineoplasic drug widely used to treat cancer. Its cytotoxic effect has been principally ascribed to the misincorporation of fluoronucleotides into DNA and RNA during their synthesis, and the inhibition of thymidylate synthase (TS) by FdUMP (one of the 5‐FU active metabolites), which leads to nucleotide pool imbalance. In the present study, we compared the ability of 5‐FU and FdUMP to induce apoptosis and to influence the cell cycle progression in human colon SW620 adenocarcinoma cells in regards to their genotoxic and clastogenic activities. Our study demonstrates that 5‐FU induces SSB, DSB and apoptosis earlier than FdUMP. Interestingly, while both drugs are able to induce apoptosis, their effect on the cell cycle progression differed. Indeed, 5‐FU induces an arrest in G1/S while FdUMP causes an arrest in G2/M. Independently of the temporal difference in strand breaks and apoptosis induction, as well as the differential cell cycle modulation, both drugs presented similar clastogenic effects. The different pattern of cell cycle arrest suggests that the two drugs induce different types of primary DNA lesions that could lead to the activation of different checkpoints and recruit different DNA repair pathways. Copyright © 2008 John Wiley & Sons, Ltd.Keywords
This publication has 33 references indexed in Scilit:
- Uracil in DNA: Consequences for carcinogenesis and chemotherapyBiochemical Pharmacology, 2008
- A microscopic technique to study kinetics and concentration–response of drug-induced caspase-3 activation on a single cell levelJournal of Pharmacological and Toxicological Methods, 2008
- Uracil incorporation into genomic DNA does not predict toxicity caused by chemotherapeutic inhibition of thymidylate synthaseDNA Repair, 2007
- Replication and homologous recombination repair regulate DNA double-strand break formation by the antitumor alkylator ecteinascidin 743Proceedings of the National Academy of Sciences, 2007
- Down-Regulation of DNA Topoisomerase IIα Leads to Prolonged Cell Cycle Transit in G2 and Early M Phases and Increased Survival to Microtubule-Interacting AgentsMolecular Pharmacology, 2005
- A Novel Polypyrimidine Antitumor Agent FdUMP[10] Induces Thymineless Death with Topoisomerase I-DNA ComplexesCancer Research, 2005
- 5-Fluorouracil incorporation into RNA and DNA in relation to thymidylate synthase inhibition of human colorectal cancersAnnals of Oncology, 2004
- The Roles of Thymidylate Synthase and p53 in Regulating Fas-Mediated Apoptosis in Response to AntimetabolitesClinical Cancer Research, 2004
- Mechanisms of Action and modulation of fluorouracilSeminars in Radiation Oncology, 1997
- New Colorimetric Cytotoxicity Assay for Anticancer-Drug ScreeningJNCI: Journal of the National Cancer Institute, 1990